Fortrea Q4 2023 Earnings Report $14.88 -0.73 (-4.68%) As of 02/21/2025 04:00 PM Eastern Earnings HistoryForecast Fortrea EPS ResultsActual EPS$0.19Consensus EPS $0.23Beat/MissMissed by -$0.04One Year Ago EPSN/AFortrea Revenue ResultsActual Revenue$775.40 millionExpected Revenue$779.09 millionBeat/MissMissed by -$3.69 millionYoY Revenue Growth+1.80%Fortrea Announcement DetailsQuarterQ4 2023Date3/11/2024TimeBefore Market OpensFTRE Upcoming EarningsFortrea will be holding an earnings conference call on Monday, March 3 at 9:00 AM Eastern. Interested parties can register for or listen to the call. Conference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseSEC FilingFTRE Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Fortrea Earnings HeadlinesFortrea Holdings Inc. Appoints New Independent DirectorFebruary 21 at 6:14 PM | tipranks.com1 Healthcare Stock to Hold Forever and 2 to IgnoreFebruary 21 at 4:56 PM | finance.yahoo.comWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."February 22, 2025 | Brownstone Research (Ad)Fortrea to Add Erin L. Russell to Board of DirectorsFebruary 21 at 3:33 PM | globenewswire.comFortrea Holdings Inc: Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical ResearchFebruary 20 at 10:11 AM | finanznachrichten.deFortrea partners with Society for Clinical Research SitesFebruary 20 at 10:11 AM | markets.businessinsider.comSee More Fortrea Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email. Email Address About FortreaFortrea (NASDAQ:FTRE), a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.View Fortrea ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
